AS

Anurag Singh

Active Director Director DIN 11268047
DIN 11268047 First appointment Sep 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Anurag Singh

Data last updated:

Anurag Singh is a Director at Adarshcure Medicity Private Limited (since 2025). The company operates in Healthcare. Adarshcure Medicity Private Limited reported revenue of ₹5.04 Cr (FY 2025).

DIN 11268047
Primary Designation Director
Industry Healthcare
First Appointment 02 Sep 2025
Largest company Adarshcure Medicity Private Limited · ₹5.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adarshcure Medicity Private Limited U93030UP2010PTC042920
Director02 Sep 2025₹5.04 Cr (FY 2025)Active

Board colleagues of Anurag Singh

NameDINCompanyDesignation
Stuti08275465Adarshcure Medicity Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adarshcure Medicity Private Limited
Premium access

Shareholding and investment profile for Anurag Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anurag Singh

Anurag Singh currently holds 1 directorship: Adarshcure Medicity Private Limited (Director, since 02 Sep 2025, revenue ₹5.04 Cr (FY 2025)).

Anurag Singh was first appointed on 02 Sep 2025 as Director at Adarshcure Medicity Private Limited.

The current boards of Anurag Singh's companies include Stuti (Adarshcure Medicity Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available